Почетна › Мажорна депресивна поремећеност › Тексас
Kliničke studije za Мажорна депресивна поремећеност u državi Тексас
38 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
- Houston21 студија
- Austin13 студија
- Grand Prairie10 студија
- Dallas9 студија
- Richardson5 студија
- Wichita Falls4 студија
- The Woodlands4 студија
- San Antonio4 студија
- Fort Worth3 студија
- Sugar Land3 студија
- Plano3 студија
Zvanični tekst studije (na engleskom)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Dallas, DeSoto
- Brain Health Consultants and TMS Center, Houston
- Flourish Research San Antonio, San Antonio
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 13. 11. 2026. · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Dallas
- Seaport Investigator Site, Irving
- Seaport Investigator Site, Richardson
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 11. 2026. · NCT07065240Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
- UTHealth Houston, Houston
- Brain Health Consultants and TMS Center, Houston
Тражи се учесник
Узраст од 22 до 85 · Оба пола · Ажурирано 9. 11. 2026. · NCT07594483A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Austin Clinical Trial Partners, Austin
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 9. 11. 2026. · NCT07592689ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Baylor College of Medicine, Houston
- Olympus Clinical Research, LLC, Katy
- Family Psychiatry of The Woodlands, The Woodlands
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 5. 11. 2026. · NCT07284667A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Dallas, DeSoto
- Re:Cognition Health - Fort Worth, Fort Worth
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Houston Clinical Trials LLC, Bellaire
- North Texas Clinical Trials, Fort Worth
- Baylor College of Medicine, Houston
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT07227454A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- FutureSearch Trials of Neurology, Austin
- Gadolin Research, Beaumont
- Adams Clinical Dallas, DeSoto
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- DM Clinical Research, Houston
- Pillar Clinical Research, LLC, Richardson
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 3. 11. 2026. · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Future Search Trials of Dallas, Dallas
- Baylor College of Medicine, Houston
- DM Clinical Research, Houston
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Dallas
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Austin
- Clinical Research Site, Dallas
- Clinical Research Site, McKinney
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07621237Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Houston Clinical Trials, Bellaire
- Baylor College of Medicine, Houston
- DM Clinical, Houston
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 10. 2026. · NCT07226661Study of ALTO-300 in MDD
- Site 316, Austin
- Site 239, Conroe
- Site 275, Houston
- и још 4
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 26. 10. 2026. · NCT05922878A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bellaire
- Neurocrine Clinical Site, Stafford
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07196501Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Texas Austin Dell Medical School, Austin
- University of Texas Southwestern Medical Center at Dallas, Dallas
- CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
- и још 1
Тражи се учесник
Узраст од 22 до 70 · Оба пола · Ажурирано 16. 10. 2026. · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, DeSoto
- Draig Clinical Site, Fort Worth
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Austin
- Clinical Research Site, Bellaire
- Clinical Research Site, Dallas
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT07484217Cortical rTMS as a Treatment for Depression
- The Menninger Clinic, Houston
Тражи се учесник
Узраст од 18 до 64 · Оба пола · Ажурирано 13. 10. 2026. · NCT05487911A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Austin
- Draig Clinical Site, Austin
- Draig Clinical Site, DeSoto
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07300969Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Houston
- Vanda Investigational Site, Plano
- Vanda Investigational Site, Richardson
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07105111Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
- Wells Medicine, Houston
- Texas A&M (Houston Methodist Hospital Location), Houston
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 21 до 45 · Оба пола · Ажурирано 15. 9. 2026. · NCT06480201Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
- Dell Medical School at University of Texas at Austin, Austin
Тражи се учесник
Узраст од 13 до 20 · Оба пола · Ажурирано 19. 8. 2026. · NCT06523439NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, DeSoto
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Austin Clinical Trial Partners, Austin
- InSite Clinical Research, LLC, DeSoto
- Grayline Research Center, Wichita Falls
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 3. 8. 2026. · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Elevate Synapsis, LLC, Atascocita
- Synapsis Bio, Atascocita
- Adams Clinical Dallas, DeSoto
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 27. 7. 2026. · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Austin Clinical Trial Partners /ID# 279321, Austin
- Community Clinical Research - Cross Park Drive /ID# 277935, Austin
- Houston Clinical Trials - Bellaire /ID# 277551, Bellaire
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Dallas, DeSoto
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 20. 5. 2026. · NCT05800925Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
- Houston Center For Advanced Psychiatric Treatment, Houston
Тражи се учесник
Узраст од 22 до 75 · Оба пола · Ажурирано 1. 5. 2026. · NCT06982820Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
- Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 1. 5. 2026. · NCT05892744Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
Тражи се учесникОпсервациона студија
Узраст од 18 до 40 · Оба пола · Ажурирано 10. 3. 2026. · NCT06740383Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #153, Beaumont
- Autobahn Site #146, San Antonio
- Autobahn Site #144, Sherman
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 1. 2026. · NCT06633016Psilocybin rTMS for Treatment Resistant Depression
- Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin
Тражи се учесникФаза 2
Узраст од 22 до 65 · Оба пола · Ажурирано 26. 11. 2025. · NCT06132178Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Dallas
- Neurocrine Clinical Site, Houston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2025. · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Dallas
- Clinical Research Site, Dallas
- Clinical Research Site, Friendswood
- и још 2
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 1. 2025. · NCT06223880Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
- Michael E. DeBakey VA Medical Center, Houston
- The University of Texas health Science Center at Houston, Houston
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 9. 1. 2025. · NCT06695767Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.